Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) GF Score: 38/100 (As of Aug. 26, 2026) — 23% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CAI:MCRO Macro Group Pharmaceuticals (Macro Capital) Co CAI:MCRO
38 GF Score
Price E£1.51
! 2 Warning Signs
View Full Analysis

What is Macro Group Pharmaceuticals (Macro Capital) Co GF Score?

Macro Group Pharmaceuticals (Macro Capital) Co CAI:MCRO -0.66% 38 GF Score is 38 as of Aug. 26, 2026, which is 23% above its 10-year median of 31.00. GuruFocus rates CAI:MCRO with a GF Score™ of 38/100. The stock has 2 warning signs investors should review.

Macro Group Pharmaceuticals (Macro Capital) Co has the GF Score of 38, which implies that the company might have Worst future performance potential, or not enough data.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 9/10
2. Profitability Rank : 5/10
3. Growth Rank : 0/10
4. GF Value Rank : 0/10
5. Momentum Rank : 0/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Macro Group Pharmaceuticals (Macro Capital) Co might have Worst future performance potential, or not enough data.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Macro Group Pharmaceuticals (Macro Capital) Co  (CAI:MCRO) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Macro Group Pharmaceuticals (Macro Capital) Co GF Score Related Terms

CAI:MCRO vs PG, CL, KVUE: GF Score Comparison

For the Household & Personal Products subindustry, Macro Group Pharmaceuticals (Macro Capital) Co's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Macro Group Pharmaceuticals (Macro Capital) Co GF Score vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Macro Group Pharmaceuticals (Macro Capital) Co's GF Score distribution charts can be found below:

* The bar in red indicates where Macro Group Pharmaceuticals (Macro Capital) Co's GF Score falls into.


CAI:MCRO
38GF Score
Macro Group Pharmaceuticals (Macro Capital) Co CAI:MCRO
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 38 mean?
Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) has a GF Score of 38 as of Aug. 26, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Macro Group Pharmaceuticals (Macro Capital) Co and its competitors. This is 23% above median its historical median of 31.00. Over the past decade, Macro Group Pharmaceuticals (Macro Capital) Co's GF Score has ranged from 27.00 to 40.00.
Is Macro Group Pharmaceuticals (Macro Capital) Co's GF Score too high?
Macro Group Pharmaceuticals (Macro Capital) Co's current GF Score of 38 is 23% above median its 10-year median of 31.00. Over the past 10 years, this metric has ranged from a low of 27.00 to a high of 40.00. Overall, Macro Group Pharmaceuticals (Macro Capital) Co has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Macro Group Pharmaceuticals (Macro Capital) Co's GF Score compare to PG and CL?
Macro Group Pharmaceuticals (Macro Capital) Co's GF Score of 38 can be compared against companies in the Consumer Packaged Goods industry. Historically, Macro Group Pharmaceuticals (Macro Capital) Co's own GF Score has ranged from 27.00 to 40.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Consumer Packaged Goods company?
A good GF Score depends on the Consumer Packaged Goods industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Macro Group Pharmaceuticals (Macro Capital) Co and its competitors. Macro Group Pharmaceuticals (Macro Capital) Co's current GF Score is 38, which is 23% above median its own 10-year median of 31.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Macro Group Pharmaceuticals (Macro Capital) Co stock overvalued right now?
Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) has a current GF Score of 38. The current GF Score is 38, which is 23% above median its 10-year median of 31.00. Macro Group Pharmaceuticals (Macro Capital) Co's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO), the current GF Score is 38 as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Macro Group Pharmaceuticals (Macro Capital) Co Business Description

Address 83, Al Moltaka Al Arabi, Sheraton, Cairo, EGY
Macro Group Pharmaceuticals (Macro Capital) Co is principally engaged in the manufacture and sale of cosmeceutical and ventured into nutraceutical products.
38GF Score

Get the complete analysis for CAI:MCRO

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

E£1.51
Price